Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

An ultra-modern Higher Education Centre of Excellence (ACE) was officially inaugurated on Friday, November 8, at the ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with ...

A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...

Our study suggests that genetic variation in our ability to digest dietary sucrose may impact not only how much sucrose we ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined ...

By Chioma Obinna On this year’s World Antimicrobial Resistance Awareness Week (WAAW), the Genomic Epidemiology of AMR ...

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, ...